Papi A - Search Results

1

Cell growth inhibition and apoptotic effect of the rexinoid 6-OH-11-O-hydroxyphenantrene on human osteosarcoma and mesenchymal stem cells.

Dozza B, Papi A, Lucarelli E, Scotlandi K, Pierini M, Tresca G, Donati D, Orlandi M. Dozza B, et al. Among authors: papi a. Toxicol In Vitro. 2012 Feb;26(1):142-9. doi: 10.1016/j.tiv.2011.10.009. Epub 2011 Oct 25. Toxicol In Vitro. 2012. PMID: 22056261

2

PPARgamma and RXRgamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models.

Papi A, Tatenhorst L, Terwel D, Hermes M, Kummer MP, Orlandi M, Heneka MT. Papi A, et al. J Neurochem. 2009 Jun;109(6):1779-90. doi: 10.1111/j.1471-4159.2009.06111.x. Epub 2009 May 11. J Neurochem. 2009. PMID: 19457135 Free article.

3

Epigenetic modifiers as anticancer drugs: effectiveness of valproic acid in neural crest-derived tumor cells.

Papi A, Ferreri AM, Rocchi P, Guerra F, Orlandi M. Papi A, et al. Anticancer Res. 2010 Feb;30(2):535-40. Anticancer Res. 2010. PMID: 20332466

4

RXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells.

Papi A, Rocchi P, Ferreri AM, Orlandi M. Papi A, et al. Cancer Lett. 2010 Nov 1;297(1):65-74. doi: 10.1016/j.canlet.2010.04.026. Epub 2010 May 26. Cancer Lett. 2010. PMID: 20510503

5

Enhanced effects of PPARgamma ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells.

Papi A, Rocchi P, Ferreri AM, Guerra F, Orlandi M. Papi A, et al. Oncol Rep. 2009 Apr;21(4):1083-9. doi: 10.3892/or_00000327. Oncol Rep. 2009. PMID: 19288012

6

Anti-invasive effects and proapoptotic activity induction by the rexinoid IIF and valproic acid in combination on colon cancer cell lines.

Papi A, Ferreri AM, Guerra F, Orlandi M. Papi A, et al. Anticancer Res. 2012 Jul;32(7):2855-62. Anticancer Res. 2012. PMID: 22753748

7

(-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.

Farabegoli F, Papi A, Orlandi M. Farabegoli F, et al. Among authors: papi a. Biosci Rep. 2011 Apr;31(2):99-108. doi: 10.1042/BSR20090143. Biosci Rep. 2011. PMID: 20446926

8

Vitexin-2-O-xyloside, raphasatin and (-)-epigallocatechin-3-gallate synergistically affect cell growth and apoptosis of colon cancer cells.

Papi A, Farabegoli F, Iori R, Orlandi M, De Nicola GR, Bagatta M, Angelino D, Gennari L, Ninfali P. Papi A, et al. Food Chem. 2013 Jun 1;138(2-3):1521-30. doi: 10.1016/j.foodchem.2012.11.112. Epub 2012 Dec 5. Food Chem. 2013. PMID: 23411276

9

A RXR ligand 6-OH-11-O-hydroxyphenanthrene with antitumour properties enhances (-)-epigallocatechin-3-gallate activity in three human breast carcinoma cell lines.

Farabegoli F, Govoni M, Ciavarella C, Orlandi M, Papi A. Farabegoli F, et al. Among authors: papi a. Biomed Res Int. 2014;2014:853086. doi: 10.1155/2014/853086. Epub 2014 Jun 11. Biomed Res Int. 2014. PMID: 25013807 Free PMC article.

10

Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines.

Papi A, Govoni M, Ciavarella C, Spisni E, Orlandi M, Farabegoli F. Papi A, et al. Curr Cancer Drug Targets. 2016;16(4):373-85. doi: 10.2174/1568009615666150817120931. Curr Cancer Drug Targets. 2016. PMID: 26278714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

589 results

Search Page

Filters